Company intelligence / Profile preview

Neocis

Miami, Florida, United States

Ownership: Private
Employees: ~140
Development stage: Other

Overview

Yomi is the first and only FDA-cleared robotic system for dental surgery, with over 35,000 robot-assisted implant cases performed as of 2024; the system is commercially available and in routine clinical use, including integration into major dental education programs, with ongoing R&D for expanding procedural indications[1][6][8]. No data on failed trials or negative outcomes was reported in the available results.

Therapeutic areas: OtherRheumatology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Boston University Henry M. Goldman School of Dental Medicine[1]

Beyond the preview

Go deeper on Neocis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neocis.

Explore the full profile